BackRBC Life Sciences Overview

RBC Life Sciences Total Liabilities

Track RBC Life Sciences's total liabilities ($5.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$5.27M
↑ 34.13% YoYΔ $1.34M vs prior year quarter

Peer trimmed avg / median

Loading

RBC Life Sciences Total Liabilities History

Loading

RBC Life Sciences vs. peers: Total Liabilities Comparison

Loading

RBC Life Sciences Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

RBC Life Sciences (RBCL) FAQ

RBC Life Sciences's total liabilities stands at $5.3M as of September 2017. That compares with $3.9M in the prior-year period — up 34.1% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

RBC Life Sciences reported $5.3M in total liabilities versus $3.9M a year earlier — a 34.1% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $3.9M in the prior-year period — up 34.1% year over year. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how RBC Life Sciences's total liabilities evolved across reporting periods, while the comparison chart places RBCL next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.